2020
Outcomes of Adults with Congenital Heart Disease Supported with Extracorporeal Life Support After Cardiac Surgery.
Dolgner SJ, Keeshan BC, Burke CR, McMullan DM, Chan T. Outcomes of Adults with Congenital Heart Disease Supported with Extracorporeal Life Support After Cardiac Surgery. ASAIO Journal 2020, 66: 1096-1104. PMID: 33136596, DOI: 10.1097/mat.0000000000001141.Peer-Reviewed Original ResearchConceptsExtracorporeal life supportAdult congenital heart diseaseFontan physiologyCardiac surgeryCongenital heart diseaseRisk factorsACHD patientsNeurologic complicationsHeart diseaseExtracorporeal Life Support Organization databaseLife supportMulticenter international registryOutcomes of adultsMultivariate logistic regressionECLS centersECLS useRenal complicationsECLS supportOverall mortalityPulmonary hemorrhageCardiopulmonary supportNeuromuscular blockadeInternational registryECLS cannulationFemale gender
2019
OUTCOMES OF ADULTS WITH CONGENITAL HEART DISEASE SUPPORTED WITH EXTRACORPOREAL LIFE SUPPORT AFTER CARDIAC SURGERY
Dolgner S, Keeshan B, Burke C, McMullan D, Chan T. OUTCOMES OF ADULTS WITH CONGENITAL HEART DISEASE SUPPORTED WITH EXTRACORPOREAL LIFE SUPPORT AFTER CARDIAC SURGERY. Journal Of The American College Of Cardiology 2019, 73: 3077. DOI: 10.1016/s0735-1097(19)33683-6.Peer-Reviewed Original Research
2018
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation
Durheim MT, Holmes DN, Blanco RG, Allen LA, Chan PS, Freeman JV, Fonarow GC, Go AS, Hylek EM, Mahaffey KW, Pokorney SD, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart 2018, 104: 1850. PMID: 29875139, DOI: 10.1136/heartjnl-2017-312735.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAnti-Arrhythmia AgentsAnticoagulantsAtrial FibrillationComorbidityFemaleHealth StatusHeart Conduction SystemHemorrhageHospitalizationHumansLungMalePrevalencePulmonary Disease, Chronic ObstructiveQuality of LifeRegistriesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeUnited StatesConceptsChronic obstructive pulmonary diseaseObstructive pulmonary diseaseAtrial fibrillationSymptom burdenHeart failurePulmonary diseaseHigh riskDiagnosis of COPDNew-onset heart failureTreatment of AFBeta-blocker useCardiovascular risk factorsMajor bleeding eventsHigh symptom burdenBetter Informed TreatmentCoronary artery diseaseOutcomes of adultsQuality of lifeBleeding eventsDigoxin useBlocker useCause mortalityProspective registryReversible causesCardiovascular mortality
2012
Outcomes of adults with restrictive cardiomyopathy after heart transplantation
DePasquale EC, Nasir K, Jacoby DL. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. The Journal Of Heart And Lung Transplantation 2012, 31: 1269-1275. PMID: 23079066, DOI: 10.1016/j.healun.2012.09.018.Peer-Reviewed Original ResearchConceptsPost-HTx outcomesUnadjusted hazard ratioRestrictive cardiomyopathyRCM patientsHazard ratioCause mortalityHeart transplantationSubgroup analysisRCM groupMultivariate Cox proportional hazards regression analysisCox proportional hazards regression analysisProportional hazards regression analysisTime of HTxProgressive heart failureRadiation/chemotherapyHazards regression analysisOutcomes of adultsPediatric restrictive cardiomyopathySpectrum of disordersAdult HTxRCM diagnosisHeart failurePatient groupSurvival outcomesUnited Network382 Outcomes of Adults with Restrictive Cardiomyopathy (RCM) Post Heart Transplant (HT): UNOS Registry Analysis
DePasquale E, Nasir K, Bellumkonda L, Mangi A, Dries D, Jacoby D. 382 Outcomes of Adults with Restrictive Cardiomyopathy (RCM) Post Heart Transplant (HT): UNOS Registry Analysis. The Journal Of Heart And Lung Transplantation 2012, 31: s135-s136. DOI: 10.1016/j.healun.2012.01.391.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply